Pruzansky A, Slade J, Stephenson M, Pursnani S
Rev Cardiovasc Med. 2024; 23(11):383.
PMID: 39076200
PMC: 11269075.
DOI: 10.31083/j.rcm2311383.
Zhou Y, Dong J, Lu H
Int J Gen Med. 2024; 17:1369-1379.
PMID: 38601195
PMC: 11005849.
DOI: 10.2147/IJGM.S458365.
Kaya A, Sahin M
Cureus. 2023; 15(8):e43829.
PMID: 37736426
PMC: 10509489.
DOI: 10.7759/cureus.43829.
Shrestha A, Mehta A, Pokharel P, Mishra A, Adhikari L, Shrestha S
Diagnostics (Basel). 2023; 13(3).
PMID: 36766599
PMC: 9913936.
DOI: 10.3390/diagnostics13030491.
Szpulak A, Garlak U, Cwirko H, Witkowska B, Rombel-Bryzek A, Witkowska D
Comput Struct Biotechnol J. 2023; 21:1022-1029.
PMID: 36694807
PMC: 9850860.
DOI: 10.1016/j.csbj.2023.01.024.
I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections.
Pandrea I, Brooks K, Desai R, Tare M, Brenchley J, Apetrei C
Front Immunol. 2022; 13:899559.
PMID: 36032119
PMC: 9411647.
DOI: 10.3389/fimmu.2022.899559.
Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With Coronavirus Disease-19.
Rabbani A, Rafique A, Wang X, Campbell D, Wang D, Brownell N
Front Cardiovasc Med. 2022; 9:876718.
PMID: 35783822
PMC: 9247184.
DOI: 10.3389/fcvm.2022.876718.
Prognostic significance of CHADS and CHADS-VASc scores to predict unfavorable outcomes in hospitalized patients with COVID-19.
Montazeri M, Keykhaei M, Rashedi S, Karbalai Saleh S, Pazoki M, Hadadi A
J Cardiovasc Thorac Res. 2022; 14(1):23-33.
PMID: 35620746
PMC: 9106940.
DOI: 10.34172/jcvtr.2022.07.
Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2.
Lawal I, Kgatle M, Mokoala K, Farate A, Sathekge M
BMC Cardiovasc Disord. 2022; 22(1):93.
PMID: 35264107
PMC: 8905284.
DOI: 10.1186/s12872-022-02534-8.
Key Characteristics of Cardiovascular Toxicants.
Lind L, Araujo J, Barchowsky A, Belcher S, Berridge B, Chiamvimonvat N
Environ Health Perspect. 2021; 129(9):95001.
PMID: 34558968
PMC: 8462506.
DOI: 10.1289/EHP9321.
Prevalence and Prognostic Value of in the Initial Presentation of SARS-CoV-2 Infection among Older Adults.
Arnau-Barres I, Pascual-Dapena A, Lopez-Montesinos I, Gomez-Zorrilla S, Sorli L, Herrero M
J Clin Med. 2021; 10(16).
PMID: 34442034
PMC: 8397085.
DOI: 10.3390/jcm10163738.
Cardiac involvement in MRI in young population after COVID-19: A single tertiary center experience.
Erdol M, Ozbay M, Yayla C, Arslan H, Ozbulbul N, Cetin E
Echocardiography. 2021; 38(8):1327-1335.
PMID: 34286876
PMC: 8444666.
DOI: 10.1111/echo.15160.
Venous and arterial thromboembolic disease in COVID-19.
Ten Berg J
J Thromb Thrombolysis. 2021; 52(4):1007-1009.
PMID: 34255267
PMC: 8276541.
DOI: 10.1007/s11239-021-02524-1.
[Neurovascular manifestations of COVID‑19].
Veltkamp R, Purrucker J, Weber R
Nervenarzt. 2021; 92(6):531-539.
PMID: 33763706
PMC: 7990492.
DOI: 10.1007/s00115-021-01104-1.
Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus?.
Riedel R, Perez-Perez A, Sanchez-Margalet V, Varone C, Maymo J
Stem Cell Res Ther. 2021; 12(1):155.
PMID: 33648582
PMC: 7919997.
DOI: 10.1186/s13287-021-02216-w.
Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance.
Wang H, Li R, Zhou Z, Jiang H, Yan Z, Tao X
J Cardiovasc Magn Reson. 2021; 23(1):14.
PMID: 33627143
PMC: 7904320.
DOI: 10.1186/s12968-021-00710-x.
Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy.
Barros I, Silva A, de Almeida L, Miranda C
Cytokine Growth Factor Rev. 2021; 58:114-133.
PMID: 33397585
PMC: 7836230.
DOI: 10.1016/j.cytogfr.2020.12.002.
Mapping COVID-19 functional sequelae: the perspective of nuclear medicine.
Brandao S, Ramos J, de Arruda G, Godoi E, Carreira L, Lopes R
Am J Nucl Med Mol Imaging. 2020; 10(6):319-333.
PMID: 33329934
PMC: 7724276.
Covid 19 and its cardiovascular effects.
Rastogi A, Tewari P
Ann Card Anaesth. 2020; 23(4):401-408.
PMID: 33109794
PMC: 7879919.
DOI: 10.4103/aca.aca_237_20.
Stroke in COVID-19: A systematic review and meta-analysis.
Nannoni S, de Groot R, Bell S, Markus H
Int J Stroke. 2020; 16(2):137-149.
PMID: 33103610
PMC: 7859578.
DOI: 10.1177/1747493020972922.
